Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

COLLEGIUM PHARMACEUTICAL, INC (COLL) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/28/2023 4 Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Sold 16,621 shares @ $21.6544, valued at $359.9k
Sold 1,363 shares @ $22.5349, valued at $30.7k
06/02/2023 4 Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Sold 31,272 shares @ $22.0887, valued at $690.8k
Sold 30,272 shares @ $21.5768, valued at $653.2k
Sold 1,000 shares @ $22.2511, valued at $22.3k
06/01/2023 4 Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Sold 31,271 shares @ $21.9023, valued at $684.9k
Sold 31,272 shares @ $21.8661, valued at $683.8k
05/19/2023 4 Balice-Gordon Rita J. (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 9,792 shares @ $0
05/19/2023 4 McFarlane Neil F. (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 9,792 shares @ $0
05/19/2023 4 Heffernan Michael Thomas (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 9,792 shares @ $0
05/19/2023 4 Freund John Gordon (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 9,792 shares @ $0
05/19/2023 4 Fallon John A. (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 9,792 shares @ $0
05/19/2023 4 Melincoff Gwen A (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 9,792 shares @ $0
05/19/2023 4 SANTINI GINO (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 9,792 shares @ $0
05/19/2023 4 BOHLIN GAREN G (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 9,792 shares @ $0
03/17/2023 4 Tupper Colleen (EVP & CFO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Sold 31,640 shares @ $23.7726, valued at $752.2k
02/14/2023 4 Smith Thomas B (EVP and Chief Medical Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 31,185 shares @ $0
02/14/2023 4 Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 48,125 shares @ $0
Granted 25,739 shares @ $0
Paid exercise price by delivering 16,291 shares @ $26.75, valued at $435.8k
Paid exercise price by delivering 7,755 shares @ $26.75, valued at $207.4k
Sold 21,811 shares @ $26.88, valued at $586.3k
02/14/2023 4 Tupper Colleen (EVP & CFO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 45,045 shares @ $0
Granted 12,565 shares @ $0
Paid exercise price by delivering 6,967 shares @ $26.75, valued at $186.4k
Paid exercise price by delivering 3,887 shares @ $26.75, valued at $104k
02/14/2023 4 Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 117,500 shares @ $0
Granted 137,694 shares @ $0
Paid exercise price by delivering 44,121 shares @ $26.75, valued at $1.2M
Paid exercise price by delivering 59,736 shares @ $26.75, valued at $1.6M
Sold 11,250 shares @ $26.88, valued at $302.4k
Exercised 11,250 options to buy @ $15.9, valued at $178.9k
02/14/2023 4 Dreyer Scott (EVP & Chief Commercial Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 44,275 shares @ $0
Granted 22,459 shares @ $0
Paid exercise price by delivering 14,529 shares @ $26.75, valued at $388.7k
Paid exercise price by delivering 6,797 shares @ $26.75, valued at $181.8k
01/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/16/2022 4 Kuhlmann Shirley R. (EVP and General Counsel) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Sold 38,589 shares @ $18.07, valued at $697.3k
08/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Ciaffoni Joseph (President and CEO) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Paid exercise price by delivering 1,394 shares @ $18.16, valued at $25.3k
05/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2022 4 Melincoff Gwen A (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC
Txns: Granted 14,035 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy